AI-Powered SEO for Regulated Healthcare Content
SatelliteAI combines enterprise SEO intelligence with compliance-grade content governance, with more than 99,000 SEO checks processed on the platform. ODIN's adversarial validation ensures medical claims are accurate before they go live. YMYL content demands the highest standards of AI citation verification.
Healthcare Content Is High Stakes
One inaccurate medical claim can trigger regulatory action, damage patient trust, or create legal liability. Traditional SEO tools were not built for this reality.
Unverified Medical Claims
AI writing tools can hallucinate drug interactions, dosages, or treatment outcomes with no validation layer. In our validation suite, ODIN cut hallucination from 5.38% to 0.54% across 372 tests -- about 90% hallucination reduction.
No Audit Trail
When FDA or legal asks "who approved this content?", most teams scramble through email threads.
Slow MLR Reviews
Medical, Legal, and Regulatory review cycles add weeks to every content update.
Missing Healthcare Schema
Most healthcare sites lack MedicalWebPage, Drug, or MedicalCondition structured data for Google Health.
Disconnected Teams
Marketing, medical affairs, regulatory, and legal work in silos with no unified content governance.
AI Overview Blind Spot
Cannot see how Google's AI summarizes your medical content or if it cites competitors instead. First Contentful Paint under 0.4 seconds correlates with roughly 3x more ChatGPT citations in our observational studies -- speed and structure matter for AI visibility.
In healthcare, a hallucinated AI citation is not a marketing problem. It is a patient safety concern that demands multi-model verification.
Built for Healthcare Compliance
SatelliteAI gives healthcare marketing teams enterprise SEO power with pharma-grade governance, including FDA 21 CFR Part 11 and EU MDR compatible controls for audit trails, signatures, and record integrity.
Compliance-Grade Workflows
Built-in Medical, Legal, and Regulatory (MLR) review workflows with full audit capabilities and localization that reaches 93-96% translation quality scores versus roughly 45% baselines in comparable tests.
- Role-based approval chains
- Electronic signatures
- Version comparison & history
- Mandatory review gates
- Time-stamped audit logs
ODIN Medical Validation
Adversarial AI verification catches medical inaccuracies before content goes live, using the same validation path that produced roughly 90% hallucination reduction across 372 tests.
- Multi-model claim verification
- Statistical confidence scoring
- Drug interaction flagging
- Dosage accuracy checks
- Citation & source validation
Adversarial AI That Catches What Others Miss
ODIN is the first validation-first AI system. Unlike single-model AI that can hallucinate confidently, ODIN uses adversarial multi-model verification with a statistical core to ensure accuracy.
For healthcare content, this means:
- 3+ AI models independently analyze medical claims for consensus
- Confidence scoring identifies low-certainty claims for human review
- Models actively challenge each other's conclusions to surface errors
ODIN Validation Flow
How medical content is verified
FDA 21 CFR Part 11 Compliance Features
Built with pharmaceutical regulatory requirements in mind from day one.
Electronic Signatures
Authenticated, time-stamped approvals for all content changes.
Full Audit Trail
Complete record of who changed what and when.
Role-Based Access
Granular permissions by role, team, and content type.
Version Control
Full history with diff comparison between versions.
Mandatory Review Gates
Content cannot publish without required approvals.
Compliance Exports
One-click audit reports for regulatory submissions.
ODIN's adversarial multi-model verification reduced hallucination from 5.38% to 0.54% across 372 tests, making it the verification layer that regulated healthcare content demands.
Common Questions
Ready to Modernize Healthcare
Content Governance?
See how SatelliteAI combines enterprise SEO power with pharmaceutical-grade compliance.